Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Mohammed Hasan Khan"'
Publikováno v:
Current Hypertension Reports. 24:435-443
With increasing survival after cancer treatment, there is a need for long-term management of risk factors and chronic medical conditions to realize the full benefit of improvement of outcomes. Hypertension is a major risk factor for cardiovascular di
Autor:
Caroline Hwang, Mohammed Hasan Khan, Monica Muppidi, Wilbert S. Aronow, Surabhi Pathak, May Nyein Chann Soe, Roshni Narurkar, Bei Jiang
Publikováno v:
Archives of Medical Science : AMS
IntroductionWe report our experience with cancer care delivery during the peak of COVID-19 pandemic in New York City.Material and methodsRetrospective analysis of the patients treated from the 1st of March, 2020 to the 8th of May, 2020.ResultsTeam hu
Autor:
Alan Gass, Mohammed Hasan Khan, Wilbert S. Aronow, Behram P. Mody, Gregg M. Lanier, Chul Ahn, Chhaya Aggarwal Gupta, Amanda Lloji, Howard A. Cooper, Avi Levine, Syed Zaid
Publikováno v:
American journal of therapeutics. 28(6)
BACKGROUND To describe baseline characteristics and outcomes in the largest known registry of advanced heart failure (HF) patients receiving continuous outpatient intravenous inotrope therapy. Studies evaluating the use of outpatient inotropes for pa
Publikováno v:
Expert Opinion on Drug Safety. 16:1407-1412
Dronedarone, a derivative of amiodarone with structural modifications, was designed to have similar electrophysiological properties with a less toxic profile. Areas covered: Brief overview of the pharmacology of dronedarone followed by a summary of r
Publikováno v:
Expert Opinion on Pharmacotherapy. 18:377-386
Current guidelines for pharmacotherapy briefly describe a role for combination antihypertensive therapy. However, guidance on whether combination therapy should be used at the time of initiating therapy or as add on, and the choice of combination the
Autor:
Mohammed Hasan Khan, Surabhi Pathak, Caroline Hwang, Monica Reddy Muppidi, Bei Jiang, May Nyein Chann Soe, Roshni Narurkar
Publikováno v:
Journal of Clinical Oncology. 39:e13500-e13500
e13500 Background: COVID-19 pandemic has affected healthcare delivery, particularly in the hard-hit areas. During the peak of COVID-19 pandemic crisis in the New York city, our outpatient oncology infusion center, located within a public teaching hos
Autor:
Tanya Dutta, Mohammed Hasan Khan, Martin H. Cohen, Joanne Bennett, Joshua Goldberg, Gilbert H.L. Tang, Daniel M. Spevack, Hasan Ahmad, Syed Zaid, Steven L. Lansman, Cenap Undemir
Publikováno v:
Journal of the American College of Cardiology. 75:1311
Post procedural mitral stenosis (PPMS) is associated with adverse outcomes in subjects undergoing transcatheter mitral valve repair (TMVR). We hypothesized that smaller mitral annular dimensions would be associated with increased risk of PPMS. 3D TEE
Autor:
Dhaval Kolte, Ankur Kalra, Sripal Bangalore, Srihari S. Naidu, Kenneth Rosenfield, Neal S. Kleiman, Douglas E. Drachman, Mohammed Hasan Khan, Deepak L. Bhatt, Tanush Gupta, J. Dawn Abbott, Poonam Velagapudi, Sahil Khera, Herbert D. Aronow, Pedro A. Villablanca
Publikováno v:
Cardiology in review. 26(6)
There are no dedicated data to guide drug-eluting stent (DES) versus bare-metal stent (BMS) selection in patients with end-stage renal disease undergoing dialysis (ESRD-D). It is unclear whether long-term benefits of a specific stent type outweigh ri
Cardiovascular (CV) disease is a major cause of morbidity and mortality in the developing and the developed world. Mortality from CV disease had plateaued in the recent years raising concerning alarms about the sustained efficacy of available prevent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0feb2476ab5e1b44972f6187bb4593d7
https://europepmc.org/articles/PMC6041873/
https://europepmc.org/articles/PMC6041873/
Autor:
Chul Ahn, Gregg M. Lanier, Behram P. Mody, Howard A. Cooper, Mohammed Hasan Khan, Wilbert S. Aronow, Syed Zaid
Publikováno v:
Journal of Cardiac Failure. 25:S17
Introduction Continuous outpatient intravenous inotrope therapy (COIIT) is a treatment strategy in stage D heart failure as bridge to advanced therapies or palliation. Studies conducted before the era of modern guideline directed medical and device t